Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
PurposeRenal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea.Materials and MethodsFrom January 2001 to December 2015, data of pediatric patients (0–18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed.ResultsAmong 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001).ConclusionThe pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.
Abstract
PurposeRenal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea.Materials and MethodsFrom January 2001 to December 2015, data of pediatric patients (0–18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed.ResultsAmong 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001).ConclusionThe pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.
참고문헌 (30)
- Brok J, "Biology and treatment of renal tumours in childhood", Eur J Cancer, 68, pp.179~195 (2016)
- Chung EM, "Renal tumors of childhood : radiologic-pathologic correlation part 1. The 1st decade : from the radiologic pathology archives", Radiographics, 36, pp.499~522 (2016)
- Nakata K, "Incidence of childhood renal tumours : an international population-based study", Int J Cancer, 147, pp.3313~3327 (2020)
- Ray S, "Pediatric and young adult renal cell carcinoma", Pediatr Blood Cancer, 67, pp.e28675~ (2020)
- Nakata K, "Comparative analysis of the clinical characteristics and outcomes of patients with Wilms tumor in the United Kingdom and Japan", Pediatr Blood Cancer, 68, pp.e29143~ (2021)
- Loke BN, "Clinical, pathological and loss of heterozygosity differences in Wilms tumors between Asian and non-Asian children", Int J Cancer, 144, pp.1234~1242 (2019)
- Ooms A, "Renal tumors of childhood : a histopathologic pattern-based diagnostic approach", Cancers(Basel), 12, pp.729~ (2020)
- Scott RH, "Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour", J Med Genet, 43, pp.705~715 (2006)
- Liu EK, "Syndromic Wilms tumor : a review of predisposing conditions, surveillance and treatment", Transl Androl Urol, 9, pp.2370~2381 (2020)
- Jain J, "Progress update in pediatric renal tumors", Curr Oncol Rep, 23, pp.33~ (2021)
- Oue T, "Management of pediatric renal tumor : past and future trials of the Japan Wilms Tumor Study Group", Pediatr Int, 57, pp.828~831 (2015)
- Dome JS, "Advances in Wilms tumor treatment and biology : progress through international collaboration", J Clin Oncol, 33, pp.2999~3007 (2015)
- Pater L, "Wilms tumor", Pediatr Blood Cancer, 2, pp.e28257~ (2021)
- Aldrink JH, "Update on Wilms tumor", J Pediatr Surg, 54, pp.390~397 (2019)
- Suh WS, "Epidemiology and clinical outcomes of childhood Wilms tumor in Korea", Korean J Pediatr Hematol Oncol, 11, pp.164~170
- 박현진, "Incidence and Survival of Childhood Cancer in Korea", Cancer Research and Treatment, 48(3), pp.869~882 (2016), 대한암학회
- Ahmed HU, "Part I : Primary malignant non-Wilms’ renal tumours in children", Lancet Oncol, 8, pp.730~737 (2007)
- van den Heuvel-Eibrink MM, "Malignant rhabdoid tumours of the kidney(MRTKs), registered on recent SIOP protocols from 1993 to 2005 : a report of the SIOP renal tumour study group", Pediatr Blood Cancer, 56, pp.733~737 (2011)
- Furtwangler R, "Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology(SIOP)93-01 and SIOP 2001 protocols : a report of the SIOP Renal Tumour Study Group", Eur J Cancer, 49, pp.3497~3506 (2013)
- 박준은, "Loss of Heterozygosity at Chromosome 16q Is a Negative Prognostic Factor in Korean Pediatric Patients with Favorable Histology Wilms Tumor: A Report of the Korean Pediatric Hematology Oncology Group (K-PHOG)", Cancer Research and Treatment, 52(2), pp.438~445 (2020), 대한암학회
- Vujanic GM, "The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol", Nat Rev Urol, 15, pp.693~701 (2018)
- de la Monneraye Y, "Indications and results of diagnostic biopsy in pediatric renal tumors : a retrospective analysis of 317 patients with critical review of SIOP guidelines", Pediatr Blood Cancer, 66, pp.e27641~ (2019)
- Rossoff J, "High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor : re-evaluating outcomes", Pediatr Hematol Oncol, 35, pp.316~321 (2018)
- Qureshi SS, "Incidence, treatment, and outcomes of primary and recurrent Non-Wilms renal tumors in children : report of 109 patients treated at a single institution", J Pediatr Urol, 16, pp.475~ (2020)
- Saula PW, "Pediatric non-Wilms’ renal tumors : a third world experience", World J Surg, 36, pp.565~572 (2012)
- Geller JI, "A prospective study of pediatric and adolescent renal cell carcinoma : a report from the Children’s Oncology Group AREN0321 study", Cancer, 126, pp.5156~5164 (2020)
- Seibel NL, "Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the Natio-nal Wilms Tumor Study-5(NWTS-5)", Pediatr Blood Cancer, 66, pp.e27450~ (2019)
- Tomlinson GE, "Rhabdoid tumor of the kidney in the National Wilms’ Tumor Study : age at diagnosis as a prognostic factor", J Clin Oncol, 23, pp.7641~7645 (2005)
- Gooskens SL, "Congenital mesoblastic nephroma 50 years after its recognition : a narrative review", Pediatr Blood Cancer, 64, pp.e26437~ (2017)
- Ahmed HU, "Part II : Treatment of primary malignant non-Wilms’ renal tumours in children", Lancet Oncol, 8, pp.842~848 (2007)